使用GLP-1R和GCGR激动剂降低体重和/或血清脂质的治疗方案和方法
本公开内容涉及双重GLP‑1R和GCGR激动剂的每周一次给药方案、制剂及使用其用于治疗有相应需要的受试者的长期体重管理和/或降低血清脂质的方法,使用包含根据SEQ ID NO:1的肽产物或与SEQ ID NO:1的肽至少80%相同的肽产物的药物剂量制剂,该受试者患有一种或更多种共病。
APPLICANTS
Browse source applicant names and unchanged name fields from imported patent records.
These are name-based results, not verified legal entities. Identical names may refer to different people or organizations; aliases and historical names are not merged.
This name was extracted from a distinct applicant node in the source XML.
1 indexed patent records
Patent counts refer to distinct records held by this site, not an applicant’s complete portfolio. A joint name field is not a single company.
Verified corpus date coverage and last import time are not currently available. Publication dates on patent records are not import dates. Cached directory results may lag behind new imports.
Search the local original applicant field containing this full text. Results may include joint lists or longer names; this is not an exact identity search.
Search patents with this applicant condition